Tus kws kho mob
QP79-23 Provider Press: Q3 2023
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 27, 2023
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 1621 - 1630 ntawm 3165
Tus kws kho mob
QP73-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tus kws kho mob
QP74-23 Commercial Pharmacy Benefit Exclusion for Abilify Asimtufii®, Adstiladrin®, Brixadi™, Glydo®, lidocaine 2%, Roctavian™, and Uzedy™
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tus kws kho mob
QP75-23 MHCP Pharmacy Benefit Exclusion for Adstiladrin®, Brixadi™, and Roctavian™
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tus kws kho mob
QP71-23 Register for Webinar | Trauma-Informed Care 102 | Tuesday, September 28, 5-6:30 pm
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tus kws kho mob
QP72-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tus kws kho mob
QP76-23 Commercial Pharmacy Benefit Exclusion for Sublocade®
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tus kws kho mob
P63-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective November 6, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P65-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Radiation Oncology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P66-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023